The Foundation is excited to announce today the creation of the Giovanis Institute for Translational Cell Biology, with a $35 million gift from researcher, philanthropist and race car driver Ted Giovanis.
The Institute will enable scientists at Johns Hopkins Medicine to study the biological roots of the most fatal aspect of cancer: how it metastasizes or spreads through the body.
The contribution is a 15-year commitment and the Institute’s researchers aim to make discoveries that reveal common features of metastasis across cancer types, with the potential to develop new therapies.
Read the full announcement from Johns Hopkins Medicine here.
Featured news
Applying nanoparticles and the immune system to fight cancer
JKTG-funded research, Iron oxide nanoparticles inhibit tumor progression and suppress lung metastases in mouse models of breast cancer, appears in the journal ACS Nano and features a collaboration between researchers at Johns Hopkins University School of Medicine and the Hormel Institute at the University of Minnesota.
Ted’s Take: It’s about the money
Money is what seems to drive things and money is what seems to drive organizations too. They all start with an overriding moral goal but after a while things often turn toward more money.
Ted’s Take: The best patient advocate? You.
When you’re a patient, you are kind of vulnerable. You have a problem, are often sketchy about what it is and the potential treatment or therapy needed. The bigger the problem, the more vulnerable you are. This makes you a perfect advocate.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133